Investor Clarus Lifesciences III, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Clarus Lifesciences III, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2023-01-12 13D/A IMGO / Imago BioSciences Inc 2,436,732 0
2022-04-01 13D/A IMGO / Imago BioSciences Inc 3,375,037 2,436,732
2022-01-12 13D/A EPIX / ESSA Pharma Inc. 3,479,114 2,187,912
2021-07-30 13D IMGO / Imago BioSciences Inc 3,375,037
2020-07-09 13D/A ETTX / Entasis Therapeutics Holdings Inc 1,623,405 1,339,836
2020-05-01 13D/A ETTX / Entasis Therapeutics Holdings Inc 1,623,405 1,623,405
2019-09-06 13D/A EPIX / ESSA Pharma Inc. 1,774,621 3,479,114
2019-08-06 13D/A AVRO / AVROBIO, Inc. 0 0
2019-08-05 13D/A AVRO / AVROBIO, Inc. 1,481,162 0
2019-05-23 13D/A AVRO / AVROBIO, Inc. 2,962,325 1,481,162
2019-01-11 13D/A EPIX / ESSA Pharma Inc. 1,774,621 1,774,621
2019-01-11 13D/A GRTS / Gritstone bio, Inc. 2,567,445 2,567,445
2019-01-11 13D/A AVRO / AVROBIO, Inc. 2,962,325 2,962,325
2019-01-11 13D/A FTSV / Forty Seven, Inc. 3,816,951 3,816,951
2019-01-11 13D/A ETTX / Entasis Therapeutics Holdings Inc 1,623,405 1,623,405
2019-01-10 13D/A AVRO / AVROBIO, Inc. 2,962,325 2,962,325
2019-01-10 13D/A GRTS / Gritstone bio, Inc. 2,567,445 2,567,445
2019-01-10 13D/A EPIX / ESSA Pharma Inc. 1,774,620 1,774,621
2019-01-10 13D/A FTSV / Forty Seven, Inc. 3,837,596 3,816,951
2019-01-10 13D/A ETTX / Entasis Therapeutics Holdings Inc 1,623,405 1,623,405
2018-10-12 13D GRTS / Gritstone bio, Inc. 2,567,445
2018-10-09 13D ETTX / Entasis Therapeutics Holdings Inc 1,623,405
2018-07-12 13D FTSV / Forty Seven, Inc. 3,837,596
2018-07-05 13D AVRO / AVROBIO, Inc. 2,962,325
2018-06-19 13D/A EPIX / ESSA Pharma Inc. 5,303,030 1,774,620
2016-02-09 13G/A EVFM / Evofem Biosciences, Inc.
2016-02-09 13G/A EVFM / Evofem Biosciences, Inc.
2016-01-26 13D EPIX / ESSA Pharma Inc. 5,303,030
2015-02-13 13G EVFM / Evofem Biosciences, Inc. 1,071,429